p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2140-2143

  Moskaluk, Christopher A ^a,b   Hruban, Ralph H ^a   Kern, Scott E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ARTICLE; CANCER INVASION; CELL DIFFERENTIATION; EPITHELIUM CELL; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; POINT MUTATION; PRIORITY JOURNAL; STEM CELL;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENES, RAS; HUMANS; MUTATION; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATIC POLYPEPTIDE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN PRECURSORS; SEQUENCE DELETION;

EID: 0030988302     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kern, S. E. Clonality: more than just a tumor-progression model. J. Natl. Cancer Inst. (Bethesda), 85: 1020-1021, 1993.
2. Holt, J. T., Jensen, R. A., and Page, D. L. Histopathology: old principles and new methods. Cancer Surv., 18: 115-133, 1993.
3. Boone, C. W., Kelloff, G. J., and Steele, V. E. The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers. J. Cell. Biochem. Suppl., 16G: 23-26, 1992.
4. Vogelstein, B., and Kinzler, K. W. The multistep nature of cancer. Trends Genet., 9: 138-141, 1993.
5. Cubilla, A. L., and Fitzgerald, P. J. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res., 36: 2690-2698, 1976.
6. Kozuka, S., Sassa, R., Taki, T., Masamoto, K., Nagasawa, S., Saga, S., Hasegawa, K., and Takeuchi, M. Relation of pancreatic duct hyperplasia to carcinoma. Cancer (Phila.). 43: 1418-1428, 1979.
7. Kloppel, G., Bommer, G., Ruckert, K., and Seifert, G. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch. A Pathol. Anat. Histol., 387: 221-233, 1980.
8. Pour, P. M., Sayed, S., and Sayed, G. Hyperplastic, preneoplastic and neoplastic lesions found in 83 human pancreases. Am. J. Clin. Pathol., 77: 137-152, 1982.
9. Riddell, R. H., Goldman, H., Ransohoff, D. F., Appelman, H. D., Fenoglio, C. M., Haggitt, R. C., Ahren, C., Correa, P., Hamilton, S. R., Morson, B. C., and et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum. Pathol., 14: 931-968, 1983.
10. Volkholz, H., Stolte, M., and Becker, V. Epithelial dysplasias in chronic pancreatitis. Virchows Arch. A Pathol. Anat. Histol., 396: 331-349, 1982.
11. Furukawa, T., Chiba, R., Kobari, M., Matsuno, S., Nagura, H., and Takahashi, T. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. Arch. Pathol. Lab. Med., 118: 227-234, 1994.
12. Longnecker, D. S. The quest for preneoplastic lesions in the pancreas. Arch. Pathol. Lab. Med., 118: 226, 1994.
13. Klimstra, D. S., and Longnecker, D. S. K-ras mutations in pancreatic ductal proliferative lesions (Letter). Am. J. Pathol., 145: 1547-1550, 1994.
14. Caldas, C., Hahn, S. A., Hruban, R. H., Redston, M. S., Yeo, C. J., and Kern, S. E. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res., 54: 3568-3573, 1994.
15. Hahn, S. A., and Kern, S. E. Molecular genetics of exocrine pancreatic neoplasms. Surg. Clin. North Am., 75: 857-869, 1995.
16. Hahn, S.A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
17. DiGiuseppe, J. A., Hruban, R. H., Offerhaus, G. J., Clement, M. J., van den Berg, F. M., Cameron, J. L., and van Mansfeld, A. D. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am. J. Pathol., 144: 889-895, 1994.
18. Tabata, T., Fujimori, T., Maeda, S., Yamamoto, M., and Saitoh, Y. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int. J. Pancreatol., 14: 237-244, 1993.
19. Tada, M., Ohashi, M., Shiratori, Y., Okudaira, T., Komatsu, Y., Kawabe, T., Yoshida, H., Machinami, R., Kishi, K., and Omata, M. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology, 110: 227-231, 1996.
20. Yanagisawa, A., Ohtake, K., Ohashi, K., Hori, M., Kitagawa, T., Sugano, H., and Kato, Y. Frequent Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res., 53: 953-956, 1993.
21. Moskaluk, C., and Kern, S. Microdissection and PCR amplification of genomic DNA from histologic tissue sections. Am. J. Pathol., in press, 1997.
22. Moskaluk, C. A., Hruban, R. H., Lietman, A., Smyrk, T., Fusaro, L., Fusaro, R., Lynch, J., Yeo, C. J., Jackson, C. E., Lynch, H. T., and Kern, S. E. Novel germline p161NK4a mutation in familial pancreatic carcinoma. Hum. Mutat., in press, 1997.
23. Schutte, M., Rozenblum, E., Moskaluk, C. A., Guan, X., Hoque, A. T., Hahn, S. A., da Costa, L. T., de Jong, P. J., and Kern, S. E. An integrated high-resolution physical map of the DPC/BRCA2 region at chromosome 13q12. Cancer Res., 55: 4570-4574, 1995.
24. Sommers, S., Murphy, S., and Warren, S. Pancreatic duct hyperplasia and cancer. Gastroenterology, 27: 629-640, 1954.
25. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 53: 549-554, 1988.